Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 13
1968 21
1969 16
1970 1
1971 4
1972 4
1973 2
1974 5
1975 3
1976 6
1977 2
1978 8
1979 1
1980 2
1982 1
1984 1
1985 1
1986 5
1987 2
1988 2
1989 1
1990 1
1991 1
1992 1
1993 2
1995 1
1996 2
1997 1
1998 1
1999 3
2000 1
2001 1
2002 1
2003 1
2004 4
2005 2
2006 3
2007 1
2008 2
2009 3
2010 2
2011 2
2012 1
2013 3
2014 5
2015 5
2016 2
2017 2
2018 10
2019 6
2020 4
2021 4
2022 4
2023 4
2024 6
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Fenaux P, et al. Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21. Lancet Oncol. 2009. PMID: 19230772 Free PMC article. Clinical Trial.
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases.
Thiele M, Villesen IF, Niu L, Johansen S, Sulek K, Nishijima S, Espen LV, Keller M, Israelsen M, Suvitaival T, Zawadzki A, Juel HB, Brol MJ, Stinson SE, Huang Y, Silva MCA, Kuhn M, Anastasiadou E, Leeming DJ, Karsdal M, Matthijnssens J, Arumugam M, Dalgaard LT, Legido-Quigley C, Mann M, Trebicka J, Bork P, Jensen LJ, Hansen T, Krag A; MicrobLiver consortium; GALAXY consortium. Thiele M, et al. Among authors: sulek k. J Hepatol. 2024 Aug;81(2):345-359. doi: 10.1016/j.jhep.2024.03.035. Epub 2024 Mar 28. J Hepatol. 2024. PMID: 38552880 Free article. Review.
Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC.
Pérez-Hernández M, van Opbergen CJM, Bagwan N, Vissing CR, Marrón-Liñares GM, Zhang M, Torres Vega E, Sorrentino A, Drici L, Sulek K, Zhai R, Hansen FB, Christensen AH, Boesgaard S, Gustafsson F, Rossing K, Small EM, Davies MJ, Rothenberg E, Sato PY, Cerrone M, Jensen THL, Qvortrup K, Bundgaard H, Delmar M, Lundby A. Pérez-Hernández M, et al. Among authors: sulek k. Circulation. 2022 Sep 13;146(11):851-867. doi: 10.1161/CIRCULATIONAHA.122.060454. Epub 2022 Aug 12. Circulation. 2022. PMID: 35959657 Free PMC article.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N; MabThera International Trial (MInT) Group. Pfreundschuh M, et al. Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21. Lancet Oncol. 2011. PMID: 21940214 Clinical Trial.
Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation.
Stafford CA, Gassauer AM, de Oliveira Mann CC, Tanzer MC, Fessler E, Wefers B, Nagl D, Kuut G, Sulek K, Vasilopoulou C, Schwojer SJ, Wiest A, Pfautsch MK, Wurst W, Yabal M, Fröhlich T, Mann M, Gisch N, Jae LT, Hornung V. Stafford CA, et al. Among authors: sulek k. Nature. 2022 Sep;609(7927):590-596. doi: 10.1038/s41586-022-05125-x. Epub 2022 Aug 24. Nature. 2022. PMID: 36002575 Free PMC article.
Defining NASH from a Multi-Omics Systems Biology Perspective.
Niu L, Sulek K, Vasilopoulou CG, Santos A, Wewer Albrechtsen NJ, Rasmussen S, Meier F, Mann M. Niu L, et al. Among authors: sulek k. J Clin Med. 2021 Oct 12;10(20):4673. doi: 10.3390/jcm10204673. J Clin Med. 2021. PMID: 34682795 Free PMC article. Review.
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes.
Rotbain Curovic V, Sørland BA, Hansen TW, Jain SY, Sulek K, Mattila IM, Frimodt-Moller M, Trost K, Legido-Quigley C, Theilade S, Tofte N, Winther SA, Hansen CS, Rossing P, Ahluwalia TS. Rotbain Curovic V, et al. Among authors: sulek k. BMJ Open Diabetes Res Care. 2024 Apr 11;12(2):e003973. doi: 10.1136/bmjdrc-2023-003973. BMJ Open Diabetes Res Care. 2024. PMID: 38604732 Free PMC article.
The Proteome of Hand Eczema Assessed by Tape Stripping.
Sølberg JBK, Quaade AS, Drici L, Sulek K, Ulrich NH, Løvendorf MB, Thyssen JP, Mann M, Dyring-Andersen B, Johansen JD. Sølberg JBK, et al. Among authors: sulek k. J Invest Dermatol. 2023 Aug;143(8):1559-1568.e5. doi: 10.1016/j.jid.2022.12.024. Epub 2023 Feb 10. J Invest Dermatol. 2023. PMID: 36773646 Free article.
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation-related markers.
Stankevic E, Israelsen M, Juel HB, Madsen AL, Ängquist L, Aldiss PSJ, Torp N, Johansen S, Hansen CD, Hansen JK, Thorhauge KH, Lindvig KP, Madsen BS, Sulek K, Legido-Quigley C, Thiele MS, Krag A, Hansen T. Stankevic E, et al. Among authors: sulek k. Liver Int. 2023 Dec;43(12):2680-2691. doi: 10.1111/liv.15692. Epub 2023 Aug 17. Liver Int. 2023. PMID: 37592403
187 results